13F-HR filed by Ally Bridge Group (NY) LLC
Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-14, with 24 holding rows worth $164,215,533.
- Accession
- 0001193125-25-283054
- Filer
- CIK 1822947
- Filed
- 2025-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2025
A holdings report, 25 entries on the cover page, a total value of $164,215,533 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,215,533 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFan Yu 028-20833
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC | 834203309 | COM | 302,483 | $20,447,851 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 250,000 | $16,900,000 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 3,600,000 | $15,084,000 | dollars as filed | call |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 32,662 | $14,980,753 | dollars as filed | |
| ATAIBECKLEY INC | N0731H103 | Equity | 2,287,005 | $12,098,256 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 51,080 | $10,155,215 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 175,363 | $8,168,409 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,145,700 | $6,564,861 | dollars as filed | call |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,898,112 | $6,206,826 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 437,391 | $5,944,144 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,026,382 | $5,881,169 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 915,000 | $5,398,500 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 100,000 | $5,300,000 | dollars as filed | call |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 64,455 | $5,264,040 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 233,220 | $4,396,197 | dollars as filed | |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 361,444 | $4,261,425 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 70,778 | $4,206,337 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 549,182 | $3,388,453 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 6,233,497 | $2,649,236 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 178,100 | $2,263,651 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 138,595 | $2,174,556 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 817,939 | $1,554,084 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 69,000 | $494,730 | dollars as filed | call |
| ATYR PHARMA INC | 002120202 | COM NEW | 600,000 | $432,840 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-25-283054 | this filing | 2025-11-14 | acceptance time not in the bulk data set |